ABSTRACT
Introduction
HIV/AIDS is not just a public health problem but it is a major developmental concern of the century [1] [2] [3] [4] [5] . The pandemic has reduced the size and productivity of the workforce as a result of excess mortality, prolonged illness that causes frequent absenteeism and a reduced working capacity [4, [6] [7] [8] . Wasting, defined conventionally as the involuntary loss of 10% or more of one's premorbid weight, contributes to this situation through an association with fatigue and an increased risk of death [9] [10] [11] [12] .
Wasting has been observed as a feature of HIV disease since the first reports of the condition [13, 14] . In industrialized countries, the prevalence of wasting in People Living with HIV (PLHIV) varies between 17 percent and 50% [15] [16] [17] [18] . In developing countries, this prevalence is difficult to determine as premorbid weight is rarely known, however, studies using the criteria Body Mass Index (BMI) < 18.5 kg/m 2 or MUAC < 22.0 cm for women and <23.0 cm for men, have demonstrated a prevalence at the time of commencing HAART of up to 25% [12, [19] [20] [21] [22] . This is almost certainly an underestimation of the true prevalence of wasting as many more PLHIV loose more than 10% of their premorbid weight Effective Therapeutic Feeding with Chickpea Sesame Based Ready-to-Use Therapeutic Food (CS-RUTF) 170 in Wasted Adults with Confirmed or Suspected AIDS without meeting the BMI or MUAC criteria mentioned above.
There is now good evidence to confirm that the presence of wasting is associated with increasing risk of mortality in PLHIV [11, 12, 16, 19, [23] [24] [25] . In the pre-HAART era, studies conducted in high-income countries showed that wasting was associated to up to 13.7% of death with individuals with moderate to severe wasting having 1.9 and 6.7 more risk of dying within the year, respectively [25, 26] . Similar results have been reported in West Africa where Van der Sande et al. noted that the baseline BMI recorded within three months of the diagnosis of HIV infection is a strong and independent predictor of mortality and the predictive power was as good as that of CD4 cell count [19] . In their study, patients with a BMI below 16 were 6.4 times more likely to die than individuals with a BMI above 22 kg/m 2 and those with BMI below 18 kg/m 2 were 3.4 times more likely to die than those with a BMI above 18 kg/m 2 [19] . Studies have shown that even after the advent of Highly Active AntiRetroviral Therapy (HAART), the mortality among PLHIV with wasting at the time of commencing HAART remain high [11, 12, 21] . In a retrospective study evaluating the outcomes of patients on HAART in Singapore, Paton et al found that BMI < 17 was a strong independent predictor of death with an adjusted hazard ratio of 2.2 [11] . A study in Malawi also found that patients with BMI < 16, 16 to 16.9 and 17 to 18.4 had, after adjustment for confounding, a 6.0, 2.4 and 2.1 fold higher risk of dying respectively within the first 3 months of HAART treatment than those who had a BMI ≥ 18.5 kg/m 2 at HAART commencement [12] . Similar results have been reported for many other developing countries including Burkina Faso, Tanzania and Zambia [21, [27] [28] [29] [30] [31] .
At present there is no consensus on how to manage PLHIV with wasting or other forms of malnutrition [32] . Various studies have examined nutritional interventions in the form of oral supplementation or total parenteral nutrition and many of these studies have reported persistence of high mortality in wasted adults receiving nutrition supplementation in combination or not with HAART [23, [32] [33] [34] . The most popular nutrition supplement used in resource-poor countries to combat wasting in PLHIV is corn soya blend mixed with vegetable oil. The first scientific evaluation on the impact of this intervention was conducted in Malawi within the Bangwe home based care programme, indicated that it had a limited impact on the nutritional status and the survival of PLHIV admitted in the programme with advanced HIV [23] . In contrast to the Bangwe findings, anecdotal results obtained with the Ready to Use Therapeutic Food (RUTF) in Malawi in children as well as in adults were encouraging [35] [36] [37] . Up to 59% of HIV positive malnourished children treated in Dowa community-based Therapeutic Care (CTC) programme, recovered with RUTF alone in absence of HAART. The majority of those who recovered retained a good nutritional status after an average 15.5 months after discharge from the programme [35] . A pilot programme conducted by Valid International has also shown that RUTF can be used to treat malnutrition in chronically sick adults at home through home based care programme structures [36] . In this programme, 54% of bedridden adults improved their physical activity by at least one grade in the Karnofsky score within the first 2 weeks of the treatment; this was accompanied with improvements in nutritional status [36] . The goal of the study was to confirm the findings of the pilot study and identify factors affecting the effectiveness of therapeutic feeding with RUTF and describe its benefits on a larger study group. This paper reports on the impact of the therapeutic feeding intervention on nutrition parameters, including anthropometric parameters, haemoglobin, physical activity performance measured by the Karnofsky score and the handgrip, and body composition.
Methods

Setting
The study was implemented in the Mangochi Health District, Malawi, between October 2006 and May 2007. Mangochi lies at the southern tip of Lake Malawi. The district had a population of around 778,338 in 2007. Although fishing is the main income generating activity of the district, subsistence farming employs 90% of the population. The estimated prevalence of HIV in the district was 21% in 2007. In the district, stigmatization is a major barrier to access health care. As a consequence both HIV testing and enrolment HAART programme are often delayed and the compliance poor. Reasons cited for this include fear of stigmatization, cost of transport and food insecurity. Save the Children and ten Community Based Organisations (CBOs) work to support PLHIV and all the participants were recruited within their catchment's areas. Free HAART was available in the area from government or mission hospital and one of the 10 CBOs offered transportation to their clients from the CBO office to the HAART clinic. 171 in Wasted Adults with Confirmed or Suspected AIDS MUAC < 22.0 cm or BMI < 17 kg/m 2 or confirmed weight loss > 10% or bilateral pitting oedema of the feet or legs. Exclusion criteria included diabetes, hypertension, known renal insufficiency, long term physical disability or inability to eat.
The key interventions included 1) nutrition education and counselling to participants and their caregivers and 2) Nutrition Support with Chickpea Sesame Based RUTF (CS-RUTF) and 3) Medical support: including Cotrimoxazole prophylaxis and treatment for minor diseases, referral and linkage with nearest health facility for management of severe medical conditions and the nearest HAART clinic for treatment.
At admission, MUAC, weight, height, sitting height and presence of bilateral oedema were checked to confirm nutrition status. Participants were classified as wasted if they had a MUAC < 22.0 cm for women and <23.0 cm for men or BMI < 18.5 kg/m 2 . They were classified as severely wasted when BMI was <16 kg/m 2 or MUAC < 18.5 kg/m 2 . The physical activity performance was measured using the Karnofsky scores and Eastern Cooperative Oncology Group (ECOG) score and handgrip. A brief medical history and physical examination was conducted to determine the clinical WHO HIV stage and identify existing morbidity. Blood was taken, to measure haemoglobin and CD4 count. The haemoglobin level was determined using a Hemacue haemoglobinometer (HeamaCue AB, Angelholm,Sweden) and participants with haemoglobin below 8 g/dl were classified as severely anaemic. Analyses for estimation of CD4 count were done using Fluorescence Activated Cell Sorter (FACS) count flow cytometer (Becton Dickinson, Singapore) at the University of North Carolina Project Laboratory in Lilongwe.
Study participants were followed up at week 2, month1 and then monthly during the therapeutic feeding phase. After discharge from the therapeutic feeding phase, study participants were followed up quarterly during 12 months. Clinical and nutrition data were collected at each follow up. Additionally, information on CS-RUTF intake was collected during the therapeutic feeding phase. Calculation of CS-RUTF intake was based on self-reporting (total number of pots eaten and daily intake during the period under review). This information was completed by the counting of terminated empty pots. Household food security conditions and the intake of additional foods were assessed at admission and during follow up. The intake of additional foods was assessed on a 24-hour and a 7-day food intake recall approach.
Study participants were discharged from the therapeutic feeding phase if they reached the discharge criteria of MUAC > 23.0 cm (minimum and maximum stay in the programme of 12 and 20 weeks) or if they decided to abandon the study or if they moved out from the study catchment area of the study or if they died. For the follow up after therapeutic feeding phase, participants were censored if they completed the 12 months or if they moved out of the study area or if they died. For this study, the weight loss prior to admission was estimated using the mean weight of rural adults Malawian published by Zverev and Chisi. Nutrition status improvement was assed using both physical activity performance criteria and anthropometric criteria. The physical activity performance criteria included improvement in Karnofsky score and increase in handgrip while the anthropometric criteria include weight, MUAC and BMI gains and achievement of the MUAC discharge criteria. We arbitrary defined static weight as a weight change ≤ 500 g.
Study Food
The composition of the CS-RUTF has been previously published [36] . Subjects were recommended to consume two pots (500 g) providing 2600 kilocalories, 61.5 g of proteins and >1 RDI for all the vitamins and minerals per day. The aim was to provide the daily requirements but participants were allowed to eat other family food because it was not suitable and impossible to impose a monotonic diet for 3 to 5 months
Data Analyses and Statistics
Data analyses were performed using SPSS 10.0 for Windows (SPSS Inc., Chicago, IL, USA). Quantitative data for normally distributed variables were described using means and standard deviation (SD) and compared using Student's t-test for 2 group comparisons and ANOVA test for multiple group comparisons; non-normally distributed variables were described using median and inter-quartile range (IQR) and compared using the Kruskall Wallis test. Dichotomous variables were compared using the Pearson or the McNemar χ 2 test as appropriate. The associations between change in nutrition status and variables upon admission and follow up were explored using the bivariate analysis followed by a stepwise logistic regression. For the logistic regression analysis, all the methods (enter, forward and backward) were used to identify the potential independent predictors. The enter method was used for the final models that included all variables selected by each of the methods. Wald statistics were used to test the statistical significance of the variables retained in the final model.
Ethical Considerations
The research protocol was submitted to the National Health Sciences Research Committee (NHSRC) and the NHSRC provided ethical approval under the number 407. Participation was voluntary. Before inclusion participants signed a consent form after receiving complete information on study objectives and procedures. The consent form that was in englesh and local language included the authorisation to participate into the study and of the publication of findings. The participant had the right to withdraw from the study at any time, during the study period. Table 1 shows that the majority of participants enrolled were female and young. More than a third had never attended school. 79.4% of the study participants had stopped working because of illness and more than 60% were bedridden (Karnofsky score < 50%) and required considerable support in daily living activities. Almost one third of them described their own health condition as poor, very poor or terrible. Coping strategies for household food insecurity were common among participants: 93.0% (180/194) used certain coping strategies before enrolment. Only 2.6% of participants had eaten food from the 6 different food group the day before admission into the study.
Results
Characteristics of Participants and Their Households
The nutrition status at admission is described in Table  2 . Of note, two third of the participants had an estimated weight loss greater than 10% and more than one third of participants were found to be severely wasted with some having also bilateral pitting oedema. The average haemoglobin was very low and severe anaemia was observed in more than a third of the participants. At the time of enrolment, women had likely loss more weight than men [mean % (SD) weight loss 18.1 (10.
At admission, all the 187 participants accepted to eat RUTF after tasting it but 9 later stopped taking CS-RUTF giving an overall dropout rate of 4.8% (9/187). Self reported intake average (SD) was 255.3 (139.0) g/day corresponding to 32.1(19.2) kcal/kg/day. Anthropometric response to the therapeutic feeding could be calculated for 154 out of 187 participants who had at least one follow up visit. The overall median (IQR) of weight gain at discharge was 0.9 (−1.9 -5.1)kg. It was 2.8 (−1.7 -6.6) kg for those who received the supplement for a minimum of 3 months. There were 3 patterns of anthropometric responses based on weight change namely continuous weight gain (WG), static weight (SW) and continuation of weight loss (WL). The distribution of the 3 patterns is 53.9% (82/154) for the WG pattern, 9.1% (14/154) for the SW pattern and 37.0% (57/154) for the WL pattern. The mean (SD) of reported daily CS-RUTF intake per body weight was 36.2 (20.0) Kcal/kg/day for the WG pattern, 30.2 (18.7) Kcal/kg/day for the SW pattern and 29.6 (15.1) Kcal/kg/day for the WL pattern (p = 0.104). The duration into the therapeutic phase was also not significantly different and was 99.4 (24.9) days fro the WG pattern, 108 (32.6) days for the SW pattern and 91.9 (35.5) days for the WL pattern, respectively (p = 0.135). The median (IQR) weight gain according to the anthropometric pattern response were 4.6 (2.4 to 7.1) kg for the WG pattern, −0.1 (−0.4 to 0.2) kg for SW pattern and −2.8 (−3.9 to −1.7) kg, for the WL pattern. Among those who remained in the programme for a minimum of 3 months, the median (IQR) weight gain were 5.7 (3.5 to 7.8) kg for WG pattern (n = 58), −0.4 (−0.5 to 0.0) kg for the SW pattern (n = 6) and −2.5 (−4.5 to −1.8) kg for WL pattern (n = 28). The changes in MUAC, BMI, and handgrip for the different patterns are presented in Table 3 . The differences in changes of MUAC, BMI and handgrip from admission to discharge were statistically significant. The difference was more important when only those who received the therapeutic food for at least 3 months were Table 4 presents the parameters recorded at admission or during the supplementation phase associated with weight gain in bivariate and logistic regression analyses. Of note, being on HAART and adhering to the number of visits were significantly and independently associated with increased chances of nutritional status improvement while the occurrence of episodes of acute diarrhoea, and complaint of poor appetite during supplementation negatively affected weight change.
As shown on Figure 1 , the percentage of patients belonging to the WG varied according to the number of risk factors (not yet on HAART, acute diarrhoea during follow up, episode of reduced appetite during follow up, missing at least one visit). All participants who did not have any of the risk factors gained weight while only 14.3% of those with all the risk factors were classified as belonging to WG pattern group (p < 0.001). The mean (SD) weight gain was 6.1 (2.9) kg for those without any of the risk factor, 3.9 (5.2) kg in presence of 1 risk factor, 1.4 (4.9) kg in presence of 2 risk factors, −0.8 (3.5) kg in presence of 3 risk factors and −2.1 (2.9) kg in presence of 4 risk factors.
Discussion
The protocol for the management of wasting in HIV individuals from household from food insecure settings is yet to be established [32, [38] [39] [40] . This situation is blamed on the absence of evidence that can help developing sound guidelines [32, 41] . The present study has contrib.-uted on the development of the evidence by demonstrating that wasting in PLHIV living in a context of widespread household food insecurity can be effectively reversed with fortified energy dense food such us CS-RUTF and that the effectiveness may be enhanced when the supplementation is integrated to other therapeutic intervention including HAART and appropriate treatment of underlying opportunistic infection.
Wasting remains an important comorbidity in AIDS patients in populations with as it is associated with increased mortality and its frequency remains high [11, 12, 21, 27, 31, 34] . A recent large study that evaluated the prevalence among patient starting HAART in Lusaka found that 17% of the 40,788 registered during the study period had a BMI < 17 kg/m 2 and the figure was 34% if the cutoff of 18.5 kg/m 2 was used [31] . In addition, evaluation of various HAART programmes have demonstrated that the presence of wasting at the time of commencing HAART, increases, by up to 6 times, the early (3-month) mortality [12, 21, 27] . The present study that was conducted at the start of the scale up of free HAART confirms that wasting is likely to remain common at the time of diagnosing HIV as most of the HIV infected wasted individuals enrolled into the study were not yet tested. Thus, for Malawi and most resource-poor countries wasting in PLHIV remains an important public health problem given the contribution of this pandemic to the overall mortality of young adults [42] .
Given the public health importance of wasting of PLHIV, it is essential for countries affected by the HIV pandemic to identify an effective intervention that can reverse the wasting process while improving the quality of life of PLHIV. Several studies have now shown that therapeutic feeding with RUTF is a promising intervention [32, [34] [35] [36] [37] . A pilot study that included 60 HIV wasted adults already demonstrated the acceptability and tolerance of CS-RUTF used in the present study [36] . The pilot study also demonstrated a clear link between the amount of CS-RUTF intake and weight gain [36] . In a cohort of wasted individuals staring HAART in Malawi, supplementary feeding with RUTF was associated with higher weight gain than supplementary feeding with porridge made from a corn soya fortified blended floor [34] . Several findings of the present study confirm the CS-RUTF effectiveness. Despite the overall low weight gain observed in the present study and the low recovery rate, the fact that adherence to the programme doubled the chances of gaining weight, the impressive weight gain of 6 kg when there were no detrimental risk factor, the higher increase in proportion of those with normal physical activity performance and those rating their health condition as fair to excellent among the WG pattern group when compared to the other groups, strongly suggest that the intervention was effective.
The results of the present study showing that some of the patients had static weight or continued to loose weight despite good intake of CS-RUTF don't have to be interpreted as an indication of ineffective therapeutic feeding. The apparently poor response was rather the consequence of the chronic inflammatory process that can be controlled by the adjunction of HAART as suggested by the strong independent relationship between HAART and the response pattern. It also outlines the fact that these patients usually present other comorbidity that interfere with nutrition recovery such us diarrhoea and oral candidiasis. HIV infection and many other chronic infections contribute to the development of wasting through an inflammatory process leading to cachexia and authors have observed that a food based intervention alone cannot reverse the cachexia process [43] . Thus, the judgment on the effectiveness of a therapeutic feeding intervention in PLHIV should take into account the quality of the management of HIV itself and of the other comorbidities.
The detrimental effect on the response to therapeutic feeding interventions targeting PLHIV of factors identified in this study namely absence of HAART, diarrhoea and oral disease have been reported before [44] [45] [46] [47] . In study carried out in the pre-HAART era, Howard et al. obtained 8% recovery rate with home parenteral nutrition after 12 months in studies conducted in north America and Europe [48] . For diarrhoea, Beaugerie et al found a direct interrelation between the clinical severity of diarrhoea and malnutrition in PLHIV, Carbonnel et al. noted that most HIV adults with weight loss of a cohort of 66 individuals had diarrhoea associated with malabsorption and Stack et al showed that weight loss in wasted HIV infected individuals with diarrhoea can occur despite a good intake of therapeutic food [44, 46, 49] . In regards of our findings and that of the literature cited, severe wasting should be considered as an independent criterion for initiating HAART. Interestingly, the WHO staging criteria currently include moderate involuntary weight loss (<10%) as a stage 3 condition and severe involuntary weight loss (>10%) as a stage 4 condition. Unfortunately, these criteria are not practical as in many resource-poor countries premorbid weight is unknown. Consequently, the level of wasting is not always used for initiating HAART. Thus, we suggest the replacement of the weight loss criteria by criteria based on anthropometric measurement as already suggested by other authors [50, 51] .
The high mortality rate of 38.5% observed in the present study has to be interpreted taking into account the fact that most of people enrolled were very sick. Almost half of them rated their health condition at admission as poor or very poor, a quarter was bedridden and unable to care for self and a third of the deaths occurred among those for whom we could not calculate weight change because the death occurred within 2 weeks of admission before the second visit. Also, only 25.7% of them have started HAART at the time of admission. However, the mortality we observed is not very much higher than the 3.5-month mortality of 27% reported by Ndekha et al. among wasted individuals treated at the teaching hospital of Malawi for whom nutritional therapy was instituted at the same time with HAART [34] . A similar high mortality of up to 88% was reported for small cohorts of AIDS patients on home parenteral nutrition in industrialized in Wasted Adults with Confirmed or Suspected AIDS countries during the pre-HAART era [52] [53] [54] [55] [56] [57] . This situation suggests that further reduction of the mortality of wasted PLHIV will probably depends in addition to early HAART initiation and effective therapeutic feeding, on the capacity of HAART programmes to diagnose and treat specific life threatening opportunistic infections.
Conclusions
In conclusion, despite some methodological limitations including the observational design of the study that prevent us from confidently attributing the observed effect to this intervention only, the limited number of participants that prevented some sub-analyses, the use of selfreported intake to estimate intake that may have resulted in overestimation of intake and adherence, the present study suggest that supplementation with CS-RUTF is an effective intervention for reversing wasting in PLHIV but has limited impact on mortality. Its effectiveness is likely to be improved by concomitant initiation of HAART and specific treatment of severe opportunistic infection. Thus, we recommend the use of CS-RUTF or other similar products for the management of wasting of PLHIV. In patients not yet on HAART, this intervention should not delay HAART initiation but should be used to enable and faster initiate HAART.
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